Cargando…
ECHO-7 oncolytic virus Rigvir® in an adjuvant setting for stage I uveal melanoma; A retrospective case report
PURPOSE: To describe a case of choroidal melanoma treated with Rigvir® virotherapy in an adjuvant setting. OBSERVATIONS: A female patient born in 1956 presented with a small choroidal melanoma in October 2007. 34 months after transpupillary thermotherapy the state of her eye worsened until tumor gro...
Autores principales: | Jaunalksne, Inta, Brokāne, Linda, Petroška, Donatas, Rasa, Agnija, Alberts, Pēteris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011033/ https://www.ncbi.nlm.nih.gov/pubmed/32072076 http://dx.doi.org/10.1016/j.ajoc.2020.100615 |
Ejemplares similares
-
Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient
por: Brokāne, Linda, et al.
Publicado: (2019) -
Effect of oncolytic ECHO-7 virus strain Rigvir on uveal melanoma cell lines
por: Tilgase, Andra, et al.
Publicado: (2020) -
A Case of Stage IV Chromophobe Renal Cell Carcinoma Treated with the Oncolytic ECHO-7 Virus, Rigvir(®)
por: Ismailov, Zaurbek, et al.
Publicado: (2019) -
Melanoma Unknown Primary Brain Metastasis Treatment with ECHO-7 Oncolytic Virus Rigvir: A Case Report
por: Proboka, Guna, et al.
Publicado: (2018) -
Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery
por: Tilgase, Andra, et al.
Publicado: (2018)